Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
Clinical trial NCT03427151 · COMPLETED
Trial details
- NCT number
- NCT03427151
- Sponsor
- ImmuPharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2019-02-05
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.